跳至主要内容
临床试验/NCT03844373
NCT03844373已完成不适用

Tolerance and Acceptability Evaluation of STOCKHOLM

Aymes International Limited2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
GI Tolerance

研究概览

简要总结

Tolerance and Acceptability of new oral nutritional supplement - STOCKHOLM.

详细描述

To evaluate tolerance and acceptability of 'STOCKHOLM' in patients requiring supplementary oral nutritional support compared with currently available alternatives.

To obtain data to support an ACBS submissions for 'STOCKHOLM' (to allow for prescription in the community at NHS expense).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are able to communicate their views regarding acceptability.
  • Patients established on an oral nutritional supplement, being prescribed ONS providing approximately 300 kcal/day
  • Patients expected to require oral nutritional supplementation for at least 2 further weeks.
  • Informed consent obtained.

排除标准

  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • Patients requiring a milk free diet
  • Patients with medical or dietary contraindication to any feed ingredients (see appendix 2 of protocol for full list)
  • Patients with significant renal or hepatic impairment
  • Patients with dysphagia requiring stage 1,2 or 3 thickened fluids
  • Patients with uncontrolled inflammatory bowel disease or previous bowel resection with ongoing gastrointestinal symptoms.

结局指标

主要结局

GI Tolerance

时间窗: 9 Days

To assess gastro-intestinal tolerance of 'STOCKHOLM' in patients in the community requiring oral nutritional supplementation. Monitoring includes recording the number and consistency of bowel movements as assessed on the Bristol stool form scale, any episodes of nausea, vomiting, abdominal pain, bloating or diarrhoea.

次要结局

  • Acceptability and Palatability of Consuming the Nutritional Supplement: Questionnaire(9 days)
  • Compliance with Prescription of STOCKHOLM(9 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验